Navigation Links
Ortho Clinical Diagnostics Launches VITROS 4600® Chemistry System for Mid- to High-Volume Laboratories

RARITAN, N.J., July 22, 2011 /PRNewswire/ -- Ortho Clinical Diagnostics (OCD) today announced the launch of the VITROS® 4600 Chemistry System, a state-of-the-art analyzer that delivers high-quality, reliable test results for mid- to high-volume laboratories using the same core technologies that drive reliability and efficiency throughout OCD's portfolio of products. The new analyzer completes the VITROS® x600 Family of Systems, which includes the VITROS® 5600 Integrated System and the VITROS® 3600 Immunodiagnostic System.  This portfolio of integrated instruments and broad, world-class menu of assays enable laboratories to deliver diagnostic results that help raise the standard of patient care in their institutions and networks.  

“In developing the VITROS® 4600 System, we stayed true to the value that our customers expect from OCD’s family of analyzers,” stated Holly Hillberg, Vice President, Research & Development. “The VITROS® Family of Systems provides sophisticated information management and interpretation tools that help reduce the potential for human error, improve operational efficiencies and ultimately help optimize patient care decisions.”

The VITROS® 4600 System is built on the same core VITROS® technologies that provide configurable, expandable automation solutions to streamline and standardize laboratory workflow while enhancing throughput. The proprietary technologies that drive this reliability and efficiency include:

  • MicroSlide Technology - allows for system operation independent of water supply and drainage and delivers high-quality results with 95 percent reportable result efficiency, minimizing operator interventions and maximizing ease of use.
  • MicroTip Technology - provides special chemistry menu offerings and user-defined assays in a format that is cost-effective and easy to implement with a low risk of carryover.
  • MicroSensor Technology - boosts efficiency and controls costs by automatically detecting and flagging issues with patient samples without compromising turnaround time or operator workflow.
  • Intellicheck™ Technology - delivers real-time process monitoring with fully documented traceability to minimize the risk of erroneous result reporting.
  • e-Connectivity® Interactive System Management - offers real-time access to information for proactive diagnosis and remote repair, maximizing uptime and increasing staff productivity.

Further, the automation-ready, point-in-space interface of the new system provides the flexibility to standardize and consolidate testing by combining the VITROS® 3600 Immunodiagnostic System and the VITROS® 5600 Integrated System on the enGen™ Laboratory Automation System.  

“The VITROS® 4600 System was developed to provide test results that laboratories and patients can count on, while optimizing staffing, supporting standardized practices and managing total operating costs,” said Peter Hoehn, Vice President, Worldwide Marketing, Clinical Laboratories.  “The design of this system is a result of actively listening and responding to the needs of our customers by investing in products, services and process solutions that meet the unique needs of modern clinical laboratories.”

As part of its commitment to customers, OCD also provides access to crucial services and solutions that help make labs more efficient in delivering the quality results doctors and patients need. 

  • To maximize uptime, OCD's industry-leading Remote Monitoring Center (RMC) - the first-of-its-kind 24 hours / 7 days a week central command center in the in vitro diagnostic industry - is designed to proactively determine the need for certain preventative intervention thus maximizing operational uptime. 
  • OCD's ValuMetrix® Services is an international strategic consulting and training service that helps healthcare organizations increase capacity, eliminate waste, and implement LEAN principles to optimize the efficiency of their operations.
  • ORTHO PLUS(SM) Inventory Management is an online service to help U.S. customers reduce manual inventory activities and lower costs by recording usage and automatically generating reorder recommendations for review by lab managers.

About the VITROS® 4600 Chemistry System

The VITROS® 4600 Chemistry System is Ortho Clinical Diagnostics' most recent addition to the VITROS® x600 family of analyzers.  It offers standardized, high quality test results using common technologies across our continuum of integrated and stand-alone systems. Beginning with dry slide technology, the VITROS® 4600 System leverages OCD's core technologies that maximize patient result quality and promote ease of use and productivity. Key features of the VITROS® 4600 Chemistry System include an intuitive, easy-to-use graphical user interface that is standardized across our family of analyzers; disposable tip metering; up to 6-month calibration stability; parallel processing of routine and special tests for uncompromised workflow; reduced maintenance requirements, adjustable thresholds for onboard inventory management and calibration expiration.  The VITROS® 4600 Chemistry System also incorporates state-of-the-art features including MicroSlide Technology, MicroTip Technology, MicroSensor Technology, Intellicheck™ Technology and e-Connectivity® Interactive System Management.  In addition, the VITROS® 4600 Chemistry System provides a comprehensive chemistry menu including therapeutic drugs, special proteins, and DAT/Toxicology.

About Ortho Clinical Diagnostics

Ortho-Clinical Diagnostics, Inc. delivers the high-quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner.  The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type and the right unit.  Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies, and automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care.  For more information, visit

SOURCE Ortho-Clinical Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Orthopaedics: Market Prospects & Global Competition
2. Daiichi Sankyo Launches LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, in Japan for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
3. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
4. Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
5. Hanger Orthopedic Group, Inc. Announces Second Quarter 2011 Earnings Release Conference Call
6. Ascension Orthopedics Announces Market Release of TITAN™ Inset Mini Glenoid
7. Ascension Orthopedics Implants PyroTITAN™ in Geelong, Australia
8. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
9. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
10. Orthopedics This Week Now on Bloomberg
11. ORTHOCON®, Inc. Receives 510(k) Clearance to Market HEMASORB Apply™
Post Your Comments:
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):